Chemomab Therapeutics (CMMB) Q2 2023 Earnings

14AugConfirmed
Aug 22
Nov 22
Q4 2022
Q2 2023
-0.72
-0.49
-0.26
-0.03

Details

Expected EPS
-0.03
Actual EPS
-0.72
Surprise EPS
-0.69
Surprise Percent
+2,300%

Description

Chemomab Therapeutics (CMMB) has reported earnings of -0.72 per share for Q2 2023.

0 Comments

Share your thoughts